Amalgamated Bank Selecta Biosciences Inc Transaction History

Amalgamated Bank

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$0.62 - $0.85 $4,866 - $6,671	-7,849 Reduced 66.71%	3,916 $3,000
Q4 2023 Feb 06, 2024	SELL	$0.67 - $1.35 $780 - $1,572	-1,165 Reduced 9.01%	11,765 $8,000
Q2 2023 Aug 11, 2023	BUY	$1.04 - $1.4 $13,447 - $18,102	12,930 New	12,930 $14,000
Q2 2022 Aug 15, 2022	SELL	$0.67 - $1.4 $7,746 - $16,186	-11,562 Closed	0 $0
Q1 2022 Jun 30, 2022	SELL	$1.23 - $3.31 $956 - $2,575	-778 Reduced 6.3%	11,562 $14,000
Q4 2021 Feb 15, 2022	SELL	$2.89 - $4.43 $575 - $881	-199 Reduced 1.59%	12,340 $40,000
Q3 2021 Oct 29, 2021	SELL	$3.36 - $4.62 $1,569 - $2,157	-467 Reduced 3.59%	12,539 $52,000
Q2 2021 Aug 16, 2021	BUY	$2.82 - $5.01 $36,676 - $65,160	13,006 New	13,006 $54,000

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.